Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

Launched by PETER SIESJÖ · Nov 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of two dietary supplements, Salovum® and SPC® flakes, on brain swelling caused by tumors. The trial aims to find out if these products can help reduce symptoms related to this swelling in patients suffering from brain tumors like glioblastoma, meningioma, and cerebral metastases. Researchers will monitor changes in brain swelling using MRI scans, as well as assess any improvements in neurological and cognitive functions over a period of 14 days.

To participate, individuals must be between 18 and 79 years old and have a confirmed or suspected brain tumor that is causing surrounding swelling and symptoms. Participants will take 11 grams of Salovum® three times daily and start taking SPC® flakes after the first week. The trial is currently recruiting and is open to all genders. If you're interested, it’s important to know that individuals with certain conditions, such as allergies to egg yolk or severe symptoms, may not be eligible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18-79 years
• • 2. Known or radiologically suspected primary or secondary brain tumor (suspected metastasis, meningioma, glioma, etc.) with surrounding edema causing clinical signs
• • 3. GCS 14-15
• • 4. WHO ECOG performance status 0-2
• • 5. Planned or started cortisone treatment
• • 6. Ability to provide informed consent
• Exclusion Criteria:
• • 1. Egg yolk allergy
• • 2. Midline shift \>5mm
• • 3. GCS ≤13
• • 4. Epilepsy as sole symptom from the cerebral edema